๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pancreatic blastomatous tumor in a child responding to therapy used for hepatoblastoma: Case report and review of the literature

โœ Scribed by Morgan, Elaine R.; Perryman, John H.; Reynolds, Marleta; Gonzalez-Crussi, Frank J.


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
867 KB
Volume
26
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


A case is reported of a 7-year-old girl diagnosed with initially inoperable metastatic embryonic pancreatic tumor, which showed a significant clinical response to chemotherapeutic agents commonly used to treat hepatoblastoma. This regimen was selected because certain histologic features of the tumor demonstrated characteristics seen in hepatic tissue. After two courses of chemotherapy (cis-platinum and adriamycin), there was a significant reduction of the primary mass, and it was completely resected, although the tumor subsequently recurred in the metastatic, unoperated site. The embryologic relationship between the tumor in this patient and hepatoblastoma, as well as the literature concerning treatment in pediatric pancreatoblastic tumors are reviewed. Complete eradication of tumor appears to be necessary for cure.


๐Ÿ“œ SIMILAR VOLUMES


Is it possible to discontinue imatinib m
โœ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o